SI
USNA icon

Sensato Investors’s Usana Health Sciences USNA Stock Holding History

Sensato Investors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,400
Closed -$453K – 83
2019
Q1 		$453K Sell
5,400
-39,184
-88% -$4.09M 0.13% 65
2018
Q4 		$5.25M Sell
44,584
-64,400
-59% -$7.45M 1.39% 30
2018
Q3 		$13.1M Buy
108,984
+80,084
+277% +$9.94M 2.27% 25
2018
Q2 		$3.33M Buy
+28,900
New +$3.16M 0.51% 41
2016
Q4 		– Sell
-3,364
Closed -$233K – 113
2016
Q3 		$233K Sell
3,364
-60,612
-95% -$4M 0.05% 71
2016
Q2 		$3.56M Buy
63,976
+14,920
+30% +$900K 0.58% 46
2016
Q1 		$2.98M Sell
49,056
-66,600
-58% -$3.92M 0.53% 51
2015
Q4 		$7.39M Sell
115,656
-143,144
-55% -$9.28M 1.39% 28
2015
Q3 		$17.3M Sell
258,800
-127,344
-33% -$9.01M 3.24% 7
2015
Q2 		$26.4M Buy
386,144
+266,200
+222% +$16.9M 5.52% 2
2015
Q1 		$6.66M Buy
+119,944
New +$6.15M 1.44% 26

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sensato Investors's USNA Position: Q2 2019 in Review

Sensato Investors sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 5,400 shares — an estimated $453K sold.

Sensato Investors first reported a position in USNA in Q1 2015 and held it in 11 quarters. The position peaked at $26.4M in Q2 2015. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

  • Sensato Investors reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
  • Sensato Investors sold 5,400 Usana Health Sciences shares in Q2 2019, an estimated $453K.
  • Sensato Investors first reported a position in Usana Health Sciences in Q1 2015 and held it in 11 quarters.
  • Sensato Investors's Usana Health Sciences position peaked at $26.4M in Q2 2015.
  • 173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Sensato Investors's 13F filing for Q2 2019, filed 14 Aug 2019.